GENI vs NRDS
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jun 27, 2026
GENI
NRDS
Investment Advisor Scores
NRDS
AI Analyst Insights
Detailed Metrics Comparison
| Metric | GENI | NRDS | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 56.8182 | 9.9108 | NRDS |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 30.5% | 6.2% | GENI |
| Earnings Growth | 0.0% | 10935.0% | NRDS |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 52.5/100 | 54.4/100 | NRDS |
| Profit Margin | -22.3% | 8.1% | NRDS |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
GENI
NeutralMixed signals - no dominant trend phase, RSI 43
NRDS
MarkdownPrice below a falling SMA50 (slope -1.3%), weak momentum, RSI 41
Fundamentals Snapshot
| Metric | GENI | NRDS |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 5.6 | 3.8 |
| Trailing P/E | — | 9.5 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.6% | 0.1% |
| Gross Margin | 0.3% | 0.9% |
| Operating Margin | -0.1% | 0.0% |
| EPS | -0.66 | 0.90 |
| Dividend Yield | — | — |